|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/551 | |
| G01N 33/569 | |||
| G01N 33/541 | |||
| G01N 33/68 |
| (11) | Number of the document | 2633321 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11837226.7 |
| Date of filing the European patent application | 2011-10-28 | |
| (97) | Date of publication of the European application | 2013-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/058457 |
| Date | 2011-10-28 |
| (87) | Number | WO 2012/058637 |
| Date | 2012-05-03 |
| (30) | Number | Date | Country code |
| 408630 P | 2010-10-31 | US |
| (72) |
JOLLY, Douglas, J., US
IBANEZ, Carlos, US
PEREZ, Omar, D., US
GRUBER, Harry, E., US
|
| (73) |
Tocagen Inc.,
3030 Bunker Hill Street Suite 230, San Diego, CA 92109,
US
|
| (54) | ANTISERA ASSAYS FOR MLV RELATED VIRUSES IN HUMANS AND OTHER MAMMALS |
| ANTISERA ASSAYS FOR MLV RELATED VIRUSES IN HUMANS AND OTHER MAMMALS |